Abstract: The present invention relates to an anti-ROS1 antibody improved in specificity for ROS1 and a use thereof and, more particularly, provides an anti-ROS1 antibody or an antigen-binding fragment thereof and a use thereof in cancer diagnosis.
Type:
Grant
Filed:
March 6, 2018
Date of Patent:
September 3, 2024
Assignees:
SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, NATIONAL CANCER CENTER, THE ASAN FOUNDATION, UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
Inventors:
Junho Chung, Eugene C. Yi, Ji Eun Kim, Hwa Kyoung Lee, Junyeong Jin, Jong Bae Park, Hyori Kim